Biomarkers|Journals Open Access|Biomarkers

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.


"Biomarkers in serum are more translatable to the clinical applications because blood samples are routinely analyzed throughout pregnancy (e.g., glucose tolerance tests). Altered biomarker levels may precede clinical symptoms and these are important for early disease detection. Two proteins are observed with time dependent changes in expression. C4 was detected as upregulated at week 12 while it wasdetected as downregulated immediately before delivery in a separate study. Alternatively, apoE expression was observed as downregulated at week 12 and upregulated at term. C4 and apoE expression are altered in the serum long before diagnosis at week 20 suggesting they may have critical roles as biomarker of preeclampsia. OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals with the support of 50,000+ editorial board members as editorial team and aimed to disseminate the scholarly knowledge to the scientific society. OMICS Group also organizing 3000+ International Scientific Conferences and events yearly all over the world with the support of 1000+ Scientific associations worldwide.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on April, 2021